pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
Endpoints·1h ago·1 min read
save

Pentagon defends labeling WuXi AppTec as Chinese military firm, warning of contract limits

Sep 21, 2026·read at Endpoints ↗RegulatoryNegative

The U.S. Department of Defense is standing by its recent decision to place WuXi AppTec on a list of companies tied to the Chinese military.

The designation could bar the contract manufacturing firm from participating in U.S. government procurement programs, potentially affecting its revenue streams.

WuXi AppTec, a major provider of pharmaceutical and biotech manufacturing services, had previously challenged the listing in court, but a federal judge only issued a temporary block.

The Pentagon says the move is based on national security concerns and will be enforced unless further legal action overturns it.

source

This writeup was produced by pharmadog from original reporting by Endpoints.

Original headline: “Pentagon defends designating WuXi AppTec as Chinese military company”

read at Endpoints ↗
82 words · retrieved 31m ago
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
Sionna Therapeutics, Inc.
topics
CRO/CDMO

related stories

  • Jul 23Repligen’s $1.5B buy for BioLife; BeOne’s $300M US expansionEndpoints
  • Jun 12WuXi AppTec sues Pentagon in challenge over inclusion on Chinese military listEndpoints
  • May 6Lonza looks to ride ADC wave with upcoming factory, workforce expansionEndpoints
  • May 15CDER chief Høeg fired from FDA as other top roles turn overEndpoints
  • May 15Post-Hoc Live: Makary's out at FDA and what comes nextEndpoints